Management Team

Mike Judy

Mike Judy joined Refocus Group in 2013 as the Chief Executive Officer, bringing with him 30 years of experience in the ophthalmology industry. Prior to joining Refocus, he most recently served as Chief Commercial Officer for AcuFocus, leading the sales and marketing team as they introduced the KAMRA™ corneal inlay.

Mr. Judy’s previous experience also includes his role as the Vice President of Global Surgical Marketing for Bausch and Lomb, where he was responsible for the cataract and refractive businesses. He joined B&L through the acquisition of Eyeonics, manufacturer of the Crystalens®. At Eyeonics, Mr. Judy led the sales and marketing team that captured the number one market share position in the premium IOL market. He has also served on various industry boards throughout his career.

Mr. Judy has a BA from Princeton University.

Martin A. Kaufman, RAC
Chief Regulatory Officer

Martin Kaufman joined Refocus Group in 2014 as Chief Regulatory Officer, and directs all Regulatory Affairs and Quality Assurance activities. His global experience with regulatory compliance plays a key role in Refocus’ clinical operations.

Previously, Martin served as Vice President of Regulatory Affairs – Cataract Surgical Products, for Alcon, managing US regulatory activities, and providing registration support to international affiliates worldwide. From 2004 to 2009, he was Director of Regulatory Affairs at Edwards Lifesciences, where he was responsible for the compilation of submissions for the US, the European Union, and Canada. Prior to Edwards, Martin directed regulatory activities for Guidant Corporation’s Coronary Stent Division based in Santa Clara, CA. From 1998 to 2002, Martin was Sr. Director – Quality and Regulatory Affairs Operations, for QLT, Inc. in Vancouver, BC, where he was key in getting Visudyne® approved in the US, Canada, the EU, and Japan.

Martin is RAC certified with the Regulatory Affairs Professional Society (RAPS) and is a member of the American Society for Quality (ASQ). He has over 34 years’ experience in Quality Assurance and Regulatory Affairs roles. Martin received a Bachelor of Science degree in Electrical Engineering Technology from California State Polytechnic University in Pomona.

George Hampton
Vice President of Marketing & Business Development

George Hampton joined Refocus Group in April 2019, bringing with him over 25 years of sales and marketing experience in ophthalmology, both in the US and internationally. Prior to coming onboard at Refocus, he was Marketing Manger of Cataract Diagnostics with Alcon Surgical, which followed his previous role as National Surgical Sales Consultant.

Mr. Hampton has more than eight years of experience with start-up companies, and most recently with WaveTec Vision as a Regional Sales Director before Alcon acquired them in 2014. At Refocus, Mr. Hampton will be overseeing marketing strategy development prior to approval and will be managing commercialization overseeing marketing and sales activities.

David Ozinga
Vice President of Manufacturing Operations

David Ozinga joined Refocus Group as Vice President of Manufacturing Operations in 2008, after nearly 20 years of medical device manufacturing and engineering experience. With roots in managing the development and manufacturing of medical devices across various health care companies, he is an accomplished industry leader.

Prior to Refocus, he was Vice President of Operations with Galt Medical, overseeing all aspects of guidewire, vascular introducer, and specialty custom kit production. From 1997 to 2004, Mr. Ozinga was Vice President of Manufacturing Operations for Imagyn Medical Technologies, where he managed the manufacturing of laparoscopic instrumentation and radioactive brachytherapy sources. He was also responsible for all supply chain management activities, developing domestic and international contract manufacturing sources for multiple products. Prior to Imagyn Medical Technologies, Mr. Ozinga worked for 10 years at B. Braun Medical in the development and manufacture of intravenous infusion systems, including the automation of numerous processes for disposable set production.

Mr. Ozinga has the CPM designation from the Institute of Supply Management, and a BS in Mechanical Engineering from Virginia Tech.

Selene A. Burke, OD
Vice President of Clinical Affairs

Dr. Selene Burke joined Refocus Group in 2006 and currently serves as Vice President of Clinical Affairs. She is a glaucoma-certified optometrist with extensive clinical experience in multispecialty practices. Since joining Refocus Group, Dr. Burke has managed the organization, training, and execution of all domestic and international clinical trials. She works alongside optometrists and ophthalmologists from around the world in implementing the VisAbility™ Procedure into their practices.

Dr. Burke began her optometric career at Vision Wellness and Laser Center in Richardson, Texas, where she provided comprehensive pre- and postoperative patient care to refractive and cataract patients while playing a significant role in establishing the practice’s first on-site laser center. During Dr. Burke’s tenure, she was also an authority on specialty contact lenses with special interests in the treatment and management of patients with irregular corneas and ocular disease. In 2004, Dr. Burke joined Vision Quest Eye Care and Surgery Center in Dallas, Texas, where she provided pre- and postoperative care to refractive, cataract, glaucoma, and retinal surgery patients. She also developed and implemented clinical protocols for ophthalmic examination, medical assisting, and insurance coding, while providing direct supervision, instruction, and training to the ophthalmic staff.

Dr. Burke received her OD from Southern College of Optometry in Memphis, Tennessee, has an MS in Zoology from Auburn University, and has a BS in Biology from Rust College.